EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem
PubMed
25687109
DOI
10.1177/2047487315569401
PII: 2047487315569401
Knihovny.cz E-zdroje
- Klíčová slova
- EUROASPIRE, cardiovascular prevention, guidelines, rehabilitation,
- MeSH
- časové faktory MeSH
- chování snižující riziko * MeSH
- cvičení MeSH
- dieta škodlivé účinky MeSH
- dodržování směrnic MeSH
- dospělí MeSH
- hodnocení rizik MeSH
- kardiologie trendy MeSH
- kardiovaskulární látky terapeutické užití MeSH
- komorbidita MeSH
- koronární nemoc diagnóza epidemiologie terapie MeSH
- kouření škodlivé účinky MeSH
- lékařská praxe - způsoby provádění trendy MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- odvykání kouření MeSH
- prevalence MeSH
- prospektivní studie MeSH
- průřezové studie MeSH
- průzkumy zdravotní péče MeSH
- rizikové faktory MeSH
- sedavý životní styl MeSH
- sekundární prevence trendy MeSH
- senioři MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- společnosti lékařské * MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
- Názvy látek
- kardiovaskulární látky MeSH
AIMS: To determine whether the Joint European Societies guidelines on cardiovascular prevention are being followed in everyday clinical practice of secondary prevention and to describe the lifestyle, risk factor and therapeutic management of coronary patients across Europe. METHODS AND RESULTS: EUROASPIRE IV was a cross-sectional study undertaken at 78 centres from 24 European countries. Patients <80 years with coronary disease who had coronary artery bypass graft, percutaneous coronary intervention or an acute coronary syndrome were identified from hospital records and interviewed and examined ≥ 6 months later. A total of 16,426 medical records were reviewed and 7998 patients (24.4% females) interviewed. At interview, 16.0% of patients smoked cigarettes, and 48.6% of those smoking at the time of the event were persistent smokers. Little or no physical activity was reported by 59.9%; 37.6% were obese (BMI ≥ 30 kg/m(2)) and 58.2% centrally obese (waist circumference ≥ 102 cm in men or ≥88 cm in women); 42.7% had blood pressure ≥ 140/90 mmHg (≥140/80 in people with diabetes); 80.5% had low-density lipoprotein cholesterol ≥ 1.8 mmol/l and 26.8% reported having diabetes. Cardioprotective medication was: anti-platelets 93.8%; beta-blockers 82.6%; angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75.1%; and statins 85.7%. Of the patients 50.7% were advised to participate in a cardiac rehabilitation programme and 81.3% of those advised attended at least one-half of the sessions. CONCLUSION: A large majority of coronary patients do not achieve the guideline standards for secondary prevention with high prevalences of persistent smoking, unhealthy diets, physical inactivity and consequently most patients are overweight or obese with a high prevalence of diabetes. Risk factor control is inadequate despite high reported use of medications and there are large variations in secondary prevention practice between centres. Less than one-half of the coronary patients access cardiac prevention and rehabilitation programmes. All coronary and vascular patients require a modern preventive cardiology programme, appropriately adapted to medical and cultural settings in each country, to achieve healthier lifestyles, better risk factor control and adherence with cardioprotective medications.
Cardiac Rehabilitation Unit Cardiology Department Hospital Universitario La Paz Madrid Spain
Cardiology Unit Department of Medicine Solna Karolinska Institutet Stockholm Sweden
Comprehensive Heart Failure Centre and Department of Medicine 1 University of Würzburg Germany
Department of Cardiology National Heart Hospital Sofia Bulgaria
Department of Cardiology Shupyk's National Medical Academy of Postgraduate Education Kiev Ukraine
Department of Heart Failure and Valve Disease Skåne University Hospital Lund Sweden
Institut Pasteur de Lille Université de Lille France
Kuopio University Hospital Finland
The Adelaide and Meath Hospital Dublin Ireland
The European Society of Cardiology Sophia Antipolis Cedex France Hacettepe University Ankara Turkey
Citace poskytuje Crossref.org
Secondary Prevention after Myocardial Infarction: What to Do and Where to Do It
